Background: This study evaluates the early and midterm results of decellularized aortic valve allografts (DAVA) as an aortic valve replacement.
Methods: Between October 2005 and February 2010, 41 patients, 28 of whom were male, with a median age of 34 years (range, 0.1 to 71), had aortic valve replacement with DAVA.